Subscribe To
Biogen and eisai strengthen lead in alzheimer's drug race. the stocks are rising.
Shares in the pharmaceutical companies rose after the publication of a paper detailing the apparent ben...
November 30, 2022, 5:11 am
Revisiting tracon pharmaceuticals
Today, we look back in on clinical stage developmental firm TRACON pharmaceuticals for the first time s...
November 30, 2022, 1:43 am
Medgene therapeutics publishes preclinical data demonstrating riv-8’s ability to overcome t cell exhaustion in the journal science advances
RIV-8 is a breakthrough technology to address T cell exhaustion GAITHERSBURG, Md., Nov. 29, 2022 (GLOBE NEWSWIRE) — MedGene Therapeutics, Inc. (MedG...
November 29, 2022, 10:00 pm
Biopharma co. trades to new 52-week high
Source: Streetwise Reports (11/28/22) Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successful...
November 29, 2022, 9:23 pm
Pharma giants take interest in acquiring horizon therapeutics
Drugmaker Horizon Therapeutics PLC is fielding takeover interest, according to people familiar with the matter, as large ...
November 29, 2022, 4:45 pm
Horizon therapeutics fields takeover interest from pharma giants
The drugmaker recently had a market value close to $18 billion as big pharmaceutical companies rely on ...
November 29, 2022, 4:21 pm
Regeneron pharmaceuticals, inc. (regn) 5th annual evercore isi healthconx conference (transcript)
Regeneron pharmaceuticals, Inc. (NASDAQ:REGN ) 5th Annual Evercore ISI HealthCONx Conference November 2...
November 29, 2022, 2:50 pm
Why is otonomy (otic) stock up 97% today?
Otonomy (NASDAQ: OTIC ) stock is on the move Tuesday despite a lack of news from the biopharmaceutical ...
November 29, 2022, 12:27 pm
Arrowhead pharmaceuticals surges after hinting at a midstage win in liver disease
Arrowhead provided a bullish update for its midstage liver disease treatment on Monday, pushing ARWR stock to rocket Tuesday. The post Arrowhead ...
November 29, 2022, 12:01 pm
Rocket pharmaceuticals: 2 regulatory filings in 2023 could propel it higher
A Rocket pharmaceuticals, Inc. regulatory filing to the FDA of LV RP-L201 for Leukocyte Adhesion Defici...
November 29, 2022, 10:50 am
Vertex pharmaceuticals: growth outside of cystic fibrosis critical for additional value creation
Vertex reported strong results in the third quarter, driven by growth in ex-U.S. markets. The cystic fibrosis franchise will soon peak due to very hig...
November 29, 2022, 9:07 am
Bristol myers squibb: share price growth in 2022 best for a decade - but 2023 could better it
Bristol Myers Squibb is a pharmaceutical powerhouse after its Celgene acquisition. The company's revenu...
November 29, 2022, 7:30 am
Arrowhead pharmaceuticals, inc. (arwr) q4 2022 earnings call transcript
Arrowhead pharmaceuticals, Inc. (NASDAQ:ARWR ) Q4 2022 Earnings Conference Call November 28, 2022 4:30 ...
November 28, 2022, 8:44 pm
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in eiger biopharmaceuticals, inc., of class action lawsuit and upcoming deadline – eigr
NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Eiger Bio...
November 28, 2022, 7:17 pm
Rallying merck stock flashing historically bullish signal
A week after announcing its acquisition of Imago Biosciences (IMGO), things are looking up for pharmaceutical<...
November 28, 2022, 1:59 pm
After plunging 35.3% in 4 weeks, here's why the trend might reverse for armata pharmaceuticals, inc. (armp)
Armata pharmaceuticals, Inc. (ARMP) has become technically an oversold stock now, which implies exhaust...
November 28, 2022, 11:17 am
Pfizer invites public to view and listen to webcast of pfizer discussion at healthcare conference
NEW YORK--( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Ang...
November 28, 2022, 10:00 am
Zynerba pharmaceuticals' zygel shows meaningful behavioral symptom treatment progress in fragile x patients in phase 3 trial
Zynerba pharmaceuticals Inc (NASDAQ:ZYNE) announced that Fragile X patients treated with Zygel showed a...
November 28, 2022, 9:45 am
Voyageur pharmaceuticals completes production testing of smoothx; begins scale-up for canadian imaging market
Voyageur pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) said it has completed the production test batch of i...
November 28, 2022, 9:11 am
Jazz pharmaceuticals to present data demonstrating advancements in epilepsy outcomes at the 2022 american epilepsy society annual meeting
Data from six abstracts to be presented, including new long-term Phase 3 results and two real-world analyses of U.S. caregiver-reported seizure and no...
November 28, 2022, 8:09 am